Literature DB >> 11545602

SuperStar: comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions.

D R Boer1, J Kroon, J C Cole, B Smith, M L Verdonk.   

Abstract

SuperStar is an empirical method for identifying interaction sites in proteins, based entirely on the experimental information about non-bonded interactions, present in the IsoStar database. The interaction information in IsoStar is contained in scatterplots, which show the distribution of a chosen probe around structure fragments. SuperStar breaks a template molecule (e.g. a protein binding site) into structural fragments which correspond to those in the scatterplots. The scatterplots are then superimposed on the corresponding parts of the template and converted into a composite propensity map. The original version of SuperStar was based entirely on scatterplots from the CSD. Here, scatterplots based on protein-ligand interactions are implemented in SuperStar, and validated on a test set of 122 X-ray structures of protein-ligand complexes. In this validation, propensity maps are compared with the experimentally observed positions of ligand atoms of comparable types. Although non-bonded interaction geometries in small molecule structures are similar to those found in protein-ligand complexes, their relative frequencies of occurrence are different. Polar interactions are more common in the first class of structures, while interactions between hydrophobic groups are more common in protein crystals. In general, PDB and CSD-based SuperStar maps appear equally successful in the prediction of protein-ligand interactions. PDB-based maps are more suitable to identify hydrophobic pockets, and inherently take into account the experimental uncertainties of protein atomic positions. If the protonation state of a histidine, aspartate or glutamate protein side-chain is known, specific CSD-based maps for that protonation state are preferred over PDB-based maps which represent an ensemble of protonation states. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545602     DOI: 10.1006/jmbi.2001.4901

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  A Bayesian molecular interaction library.

Authors:  Ville-Veikko Rantanen; Mats Gyllenberg; Timo Koski; Mark S Johnson
Journal:  J Comput Aided Mol Des       Date:  2003-07       Impact factor: 3.686

2.  Ligand-binding site prediction of proteins based on known fragment-fragment interactions.

Authors:  Kota Kasahara; Kengo Kinoshita; Toshihisa Takagi
Journal:  Bioinformatics       Date:  2010-05-13       Impact factor: 6.937

Review 3.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

4.  Distilling the essential features of a protein surface for improving protein-ligand docking, scoring, and virtual screening.

Authors:  Maria I Zavodszky; Paul C Sanschagrin; Rajesh S Korde; Leslie A Kuhn
Journal:  J Comput Aided Mol Des       Date:  2002-12       Impact factor: 3.686

5.  Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; Benjamin Z Stanton; Jotaro Igarashi; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

6.  Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis.

Authors:  Jason C Cole; Ilenia Giangreco; Colin R Groom
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-02-22       Impact factor: 7.652

7.  The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.

Authors:  Colin R Groom; Jason C Cole
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-02-22       Impact factor: 7.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.